1[1]Mourad G,Garrigue,V,et al.Inductin versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression [J].Transplantation,2001,72(6):1050-5.
2[2]Neu AM,Benfield M.What is the role for mycophenolate mofetil in pediatric renal transplantation [J]?Pediatr Transplant,1999,3(1):83-7.
3[3]Montagnino G,et al.Long-term results with cyclosporine monotherapy in renal transplant patients:a multivariate analysis of risk factors [J].American Journal of Kidney Diseases,2000,35(6):1135-43.
4[4]Smak Gregoor PJ,van Gelder T,et al.Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction [J].Transplantation,2000,70(1):143-8.
5[5]Sandrini S,Maiorca R,Scolari,F,et al.A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal,6 months after renal transplantation [J].Transplantation,2000,69(9):1861-7.
6[6]Tong CY,Bakran A,Williams H,Cheung CY,Peiris JS,Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients [J].Transplantation,2000,70(1):213-6.
7[7]Brennan DC,Storch GA,Singer GG,Lee L,Rueda J,Schnitzler MA.The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir [J].Journal of Infections Diseases,2000,181(5):1557-61.
8[8]Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation [C].Cochrane reviews issue,2002.3.
9[9]van Riemsdijk IC,Mulder PG,et al.Addition of isradipine (Lomir) results in a better renal function after kidney transplantation:a double-blind,randomized,placebo-controlled,multi-center study [J].Transplantation,2000,70(1):122-6.
10[10]Asberg A,Midtvedt K,Vassbotn T,Hartmann A.Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients [J].Nephrology Dialysis Transplantation,2001,16(7):1465-70.
6Neu AM,Benfield M.What is the role for mycophenolate mofetil in pediatric renal transplantation.Prdiatr[J].Transplant,1999,3(1):83
7Singh N.Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation[C].Cochrane reviews issue,2002:3
8Brennan DC,Storch GA,Singer GG,et al.The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir[J].Journal of Infections Diseases,2000,181(5):1557
